- Home
- BIRD vs OMIC Comparison
BIRD vs OMIC Comparison
Compare BIRD & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRD
- OMIC
- Stock Information
- Founded
- BIRD 2015
- OMIC 2016
- Country
- BIRD United States
- OMIC United States
- Employees
- BIRD N/A
- OMIC 127
- Industry
- BIRD Apparel
- OMIC Medical/Dental Instruments
- Sector
- BIRD Consumer Discretionary
- OMIC Health Care
- Exchange
- BIRD Nasdaq
- OMIC Nasdaq
- Market Cap
- BIRD 55.3M
- OMIC 49.9M
- IPO Year
- BIRD 2021
- OMIC 2021
- Fundamental
- Price
- BIRD $6.95
- OMIC $19.70
- Analyst Decision
- BIRD Hold
- OMIC Hold
- Analyst Count
- BIRD 3
- OMIC 2
- Target Price
- BIRD $18.00
- OMIC $10.75
- AVG Volume (30 Days)
- BIRD 65.9K
- OMIC 21.3K
- Earning Date
- BIRD 03-11-2025
- OMIC 11-12-2024
- Dividend Yield
- BIRD N/A
- OMIC N/A
- EPS Growth
- BIRD N/A
- OMIC N/A
- EPS
- BIRD N/A
- OMIC N/A
- Revenue
- BIRD $205,895,000.00
- OMIC $2,667,000.00
- Revenue This Year
- BIRD N/A
- OMIC $0.82
- Revenue Next Year
- BIRD N/A
- OMIC $252.64
- P/E Ratio
- BIRD N/A
- OMIC N/A
- Revenue Growth
- BIRD N/A
- OMIC 2.77
- 52 Week Low
- BIRD $6.11
- OMIC $5.34
- 52 Week High
- BIRD $22.40
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- BIRD 43.94
- OMIC 48.55
- Support Level
- BIRD $6.11
- OMIC $19.25
- Resistance Level
- BIRD $7.08
- OMIC $19.90
- Average True Range (ATR)
- BIRD 0.45
- OMIC 0.32
- MACD
- BIRD 0.05
- OMIC 0.02
- Stochastic Oscillator
- BIRD 56.53
- OMIC 54.55
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.